Startseite/Aktien/VNDA

VNDA

USD

Vanda Pharmaceuticals Inc. Common Stock

$4.350-0.040 (-0.911%)

Echtzeitkurs

Healthcare

Biotechnologie

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$4.390

Hoch

$4.430

Tief

$4.324

Volumen

0.36M

Unternehmensfundamentaldaten

Marktkapitalisierung

257.1M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.53M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $3.81Aktuell $4.350Hoch $5.7

Ähnliche Nachrichten

30. Okt. 2025 · 13:48

Analyst Upgrades

Cantor Fitzgerald Maintains Overweight on Vanda Pharmaceuticals, Lowers Price Target to $11

Cantor Fitzgerald analyst Olivia Brayer maintains Vanda Pharmaceuticals with a Overweight and lowers the price target from $13 to $11.

Cantor Fitzgerald Maintains Overweight on Vanda Pharmaceuticals, Lowers Price Target to $11

22. Okt. 2025 · 20:30

PR Newswire

Vanda Pharmaceuticals to Announce Third Quarter 2025 Financial Results on October 29, 2025

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2025 on Wednesday, October 29, 2025,...

Vanda Pharmaceuticals to Announce Third Quarter 2025 Financial Results on October 29, 2025

Ähnliche Aktien

BASE

Couchbase Inc.

NASDAQ

Computersoftwar...

GLQ

Clough Global Equity Fund Clough Global Equity Fund Common Shares of Beneficial Interest

NASDAQ

Finance/Investo...

ALLR

Allarity Therapeutics Inc.

NASDAQ

Biotechnologie:...

EVLV

Evolv Technologies Holdings Inc.

NASDAQ

Computer-Periph...

KSS

Kohl's Corporation

NASDAQ

Department/Spec...

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.